BioXcel Therapeutics
BTAI
#9823
Rank
โ‚ฌ15.79 M
Marketcap
0,33ย โ‚ฌ
Share price
8.12%
Change (1 day)
-88.11%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ38.69 Million

According to BioXcel Therapeutics's latest financial reports the company has โ‚ฌ38.69 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ0.18 B-12.21%
2021-12-31โ‚ฌ0.20 B18.72%
2020-12-31โ‚ฌ0.17 B498.6%
2019-12-31โ‚ฌ28.94 M-22.2%
2018-12-31โ‚ฌ37.2 M4933.07%
2017-12-31โ‚ฌ0.73 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.26 B 574.40%๐Ÿ‡บ๐Ÿ‡ธ USA